Physician profile
Brian J Miles
NPI 1780774752
$34,578.25
in general payments reported to CMS, 2019-2025
27 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,731 · 2020: $1,485 · 2021: $545 · 2022: $6,936 · 2023: $22K · 2024: $767 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $5,549 · Food and Beverage: $1,588 · Education: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,500.00 |
| Travel and Lodging | $5,548.57 |
| Food and Beverage | $1,587.90 |
| Education | $245.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $23,896.07 | 2019-2025 | |
| Intuitive Surgical, INC. | $7,625.33 | 2019-2025 | Da Vinci Surgical System |
| Ethicon INC. | $493.77 | 2025 | Echelon Flex |
| Biotissue Holdings INC. | $254.49 | 2023-2024 | |
| Procept Biorobotics Corporation | $220.94 | 2020-2022 | |
| Boston Scientific Corporation | $217.44 | 2019-2023 | |
| Astellas Pharma US INC | $209.03 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $164.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $163.60 | 2021-2024 | |
| Medical Device Business Services, INC. | $158.84 | 2025 | |
| Allergan, INC. | $146.95 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $128.13 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $119.65 | 2021-2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $112.12 | 2021 | |
| Urogen Pharma, INC. | $106.44 | 2021-2023 | Jelmyto |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $105.81 | 2024 | Perclot |
| Janssen Biotech, INC. | $99.95 | 2024 | Erleada |
| Tempus Ai, INC | $99.52 | 2024 | |
| Ambu INC. | $46.65 | 2023-2025 | |
| Coloplast Corp | $40.31 | 2019 | |
| Abbvie INC. | $39.19 | 2022 | |
| Urovant Sciences INC | $34.66 | 2022 | |
| Convatec INC. | $22.86 | 2023 | |
| Ethicon US, LLC | $20.64 | 2021 | |
| Dentsply Ih INC. | $19.62 | 2021 | |
| Medical Microinstruments, INC. | $18.63 | 2024 | Symani Surgical Systems |
| Myovant Sciences INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.